ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

PHC Plant Health Care Plc

3.47
-0.33 (-8.68%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Plant Health Care Plc LSE:PHC London Ordinary Share GB00B01JC540 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.33 -8.68% 3.47 3.30 3.64 3.70 3.64 3.70 110,904 16:35:23
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pesticides, Agric Chems, Nec 11.77M -9.48M -0.0278 -1.31 12.43M
Plant Health Care Plc is listed in the Pesticides, Agric Chems sector of the London Stock Exchange with ticker PHC. The last closing price for Plant Health Care was 3.80p. Over the last year, Plant Health Care shares have traded in a share price range of 3.20p to 11.40p.

Plant Health Care currently has 341,532,952 shares in issue. The market capitalisation of Plant Health Care is £12.43 million. Plant Health Care has a price to earnings ratio (PE ratio) of -1.31.

Plant Health Care Share Discussion Threads

Showing 426 to 449 of 1375 messages
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older
DateSubjectAuthorDiscuss
10/8/2016
11:45
hxxp://www.planthealthcare.com/new-technology/

lots of sound information

dadedidodu
10/8/2016
11:44
‘PREtec’ platform
Plant Health Care is the world leader in Plant Response Elicitor technology, a class of bio-rational agricultural technology known as PREtec.

pretec-logo
PREtec elicitors selectively activate the innate growth and defense mechanisms of crop plants, leading to higher yields and better protection against pests and pathogens.

The Group’s new technology segment is focused on the invention and early development of PREtec signal peptides and the elucidation of their mode of action.

Plant Health Care has historic capabilities in this field going back to the discovery and development of Harpins, which are pathogen-derived effector molecules.

dadedidodu
10/8/2016
11:44
‘PREtec’ platform
Plant Health Care is the world leader in Plant Response Elicitor technology, a class of bio-rational agricultural technology known as PREtec.

pretec-logo
PREtec elicitors selectively activate the innate growth and defense mechanisms of crop plants, leading to higher yields and better protection against pests and pathogens.

The Group’s new technology segment is focused on the invention and early development of PREtec signal peptides and the elucidation of their mode of action.

Plant Health Care has historic capabilities in this field going back to the discovery and development of Harpins, which are pathogen-derived effector molecules.

dadedidodu
10/8/2016
11:41
top of the movers board now sky ship


This could be six bagger

abarclay
10/8/2016
11:38
24p!!! - Be very careful newcomers - note the massively dilutive placing going through at a mere 10p!
skyship
10/8/2016
11:38
lots of interest here
abarclay
10/8/2016
11:30
only 5,000 shares now avail at 25p on board
abarclay
10/8/2016
11:28
And she's away to the races
abarclay
10/8/2016
11:26
Avoid like the plague


Unmitigated disaster

abarclay
10/8/2016
11:25
MASSIVE BOWL ON CHART TO 120p
abarclay
28/7/2016
12:22
Chart and above comments appear (imo) to be saying PHC is on the way out - Not sure if any value left in the IP -
pugugly
19/6/2016
11:31
Yes - phc is a lemon!
targatarga
19/6/2016
08:38
Any news on the big drop on Friday?
leonmoon
09/4/2016
11:56
Thanks for that Thomas. Held these for a good while now and they are pretty volatile. Have you got the full broker report that you could post on here? Have considered topping up but £38m market cap seems high enough for a company that has never turned a profit and whose losses are likely to continue in the next couple years. Also, they are going to require further funding later this year. Also some of the patent protection starts to expire in 2017 (although presumably not the 3G products).
callumross
08/4/2016
14:30
Read Liberum's note on Plant Health Care (PHC), out this morning, by visiting www.research-tree.com …
“FY15 sales +9% (+15% in l.c.) with gross margins jumping to 62% from 51% last year with better product mix. A doubling R&D led to higher opex driving FY net loss to $8m vs. $6m in FY14. Net cash ended FY15 at $8.4m vs. $16.6m last year. Looking ahead we are not changing estimates materially. We expect further sales growth in existing products and R&D ramp up. PHC is excited by R&D progress and expects to introduce a 2nd peptide family for evaluation this year with trials for the 1st peptide family (Innatus 3G) going well. Innatus 3G license auctions are now expected in 2017/18. Licenses for its other peptide technologies are targeted earlier than this. We believe the recent share price fall is vastly overdone...”

thomasthetank1
17/9/2015
12:53
LONDON (Alliance News) - Liberum said the narrowed pretax profit loss reported by Plant Health Care for the first half of 2015 was in line with the broker's expectations, who retained a Hold stance on the stock. For the half year to end-June, the company reported a pretax loss of USD3.0 million, narrowed from a pretax loss of USD3.7 million, as a slight decline in revenue to USD3.2 million from USD3.3 million was offset by lower sales and marketing and administrative costs. Liberum noted that Plant Health Care, which provides biological products for the agriculture markets, "remains excited" about the prospects for the agreement the group signed with an agriculture company related to its Innatus 3G peptide platform. Innatus technology enables the design, screening and production of a large pipeline of peptides with diverse bio-stimulant properties. The peptides can provide improved yields, pest and disease resistance, and protection against abiotic stress in a wide range of crops, Plant Health Care said back in June, when the agreement was announced, with no financial details. The broker said it believes that Plant's bio-stimulant technology could be "transformational" and generate substantial revenues. However, Liberum warned that the commercial business remains loss making and the first Innatus revenues are not expected until 2017. Liberum retained its 120 pence price target. Shares in Plant Health Care were untraded Monday at 98p, having dropped by 17% year to date. By Daniel Ruiz; danielruiz@alliancenews.com Copyright 2015 Alliance News Limited. All Rights Reserved.
callumross
08/4/2015
08:54
Plant Health Care (AIM: PHC), a leading provider of novel patent-protected biological products to the global agriculture markets, is pleased to announce that it has signed an agreement with a major industry player in the agricultural space regarding the evaluation of its Innatus(TM) 3G peptide platform.

No name given ?

Licensing out their IP to large scale users, with royalties on sales to follow, could be a game changer. A bit like a small biotech licensing an early stage drug development to a big pharmaceutical company.

mdrans1
17/2/2015
21:56
Richard Griffiths now upto 20%
oilbuy
06/11/2014
19:07
Yes indeed coincall.
blueball
06/11/2014
18:37
What price now blueball?
coincall
03/11/2014
17:09
95p today looking good for 100p.
blueball
07/6/2014
17:04
Richard Griffiths just bought some more shares now he owns 17%. He can see this share turning cash flow positive soon.
johnsmith321
26/3/2014
09:30
Glad I got out of this one now at 60p.
callumross
24/3/2014
07:52
A great pile of nothing - Announcement is great for the first paragraphs. THEN get onto the accounts for a LOSS of 6,883,000.

OK Revenue improving but (imo) no way this will become cash flow positive in teh foreseeable future.

Other views ??

pugugly
Chat Pages: Latest  19  18  17  16  15  14  13  12  11  10  9  8  Older

Your Recent History

Delayed Upgrade Clock